Oncolys BioPharma Inc.

TSE:4588.T

709 (JPY) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024202320222021202020192018201720162015201420132012
Operating Activities:
Net Income -1,684.778-1,938.505-1,146.005-1,611.714-2,091.359-908.593-1,230.105-1,087.185-928.344-854.701-737.106-633.193-100.513
Depreciation & Amortization 0.8152.2860.9146.4864.893.1091.7091.16215.36416.76412.55117.13916.953
Deferred Income Tax 00061.68377.399364.0590000000
Stock Based Compensation 25.63110.06258.134208.951376.608125.9280000000
Change In Working Capital -227.655531.601-501.782-532.585-129.755148.73337.03613.429-60.24593.755-65.4948.844-107.876
Accounts Receivables 0151.42698.079-208.6371.867-118.92438.352-22.885-65.0429.936000
Inventory 0.76418.907-12.593-1.1834.444-3.8557.519-3.4630.5923.072.832-3.5610.795
Accounts Payables 00-98.079208.637-1.867118.9240000000
Other Working Capital -228.419361.268-489.189-531.402-134.199152.58829.51716.892-60.83790.685-68.32612.405-108.671
Other Non Cash Items -134.10157.634-128.396125.355-2.98228.5363.781-24.24669.801-11.574-24.448.68240.087
Operating Cash Flow -2,020.088-1,336.922-1,717.135-1,741.827-1,465.199-238.228-1,187.579-1,096.84-903.424-755.756-814.489-598.528-151.349
Investing Activities:
Investments In Property Plant And Equipment -3.519-5.686-1.358-1.437-2.7-4.29-1.643-1.436-20.994-4.175-23.085-0.678-15.374
Acquisitions Net 00.13600-10.76300-11.079-10.1734.1759.8770-10.86
Purchases Of Investments 0-0.001-0.001-0.001-0.006-0.006-356.316-455.676-512.638-245.236-3,545.016-75-417.12
Sales Maturities Of Investments 0000.486-21.7620700600798.5912,000175187.138172.879
Other Investing Activites -1.1860.15921.4760.01-2.346-0.146-0.001-0.1471.8410.044-25.478-1.002-0.879
Investing Cash Flow -4.705-5.39220.117-0.942-37.577-4.442342.04131.662256.6271,754.808-3,408.702110.458-271.354
Financing Activities:
Debt Repayment -6.369-98.984-111.104-24.841-3.147122.216-53.15874.574-43.886-113.33611.858214.5108.5
Common Stock Issued 01,223.4503,085.424245.5051,006.8921,188.3281,409.38236.8780.125.665,232.936255.905
Common Stock Repurchased -5.0020-0.028-0.036-0.09500000-15.124-25.0240
Dividends Paid 0000000000-35.074-240.1710
Other Financing Activities 2,890.81518.076-2.69830.837-0.002-5.79612.1-7.45313.431-6.844-2.62717.669-1.954
Financing Cash Flow 2,879.4441,142.542-113.833,091.384242.2611,123.3121,147.271,476.5036.423-120.06-0.2335,440.081362.451
Other Information:
Effect Of Forex Changes On Cash 23.50421.33467.41338.171-14.147-1.201-6.111-7.864-0.885-1.2041.2828.7431.44
Net Change In Cash 878.155-178.438-1,743.4341,386.785-1,274.664879.44295.62503.461-641.259877.786-4,222.1444,980.755-54.953
Cash At End Of Period 2,165.9181,287.7631,466.2013,209.6351,822.853,097.5142,218.0741,922.4541,418.9932,060.2521,182.4665,404.61423.855